Prawo i regulacje · 26/02/2016

DEA Removes Exemption Rule for DaTscan Administering Personnel

The Drug Enforcement Administration (DEA) has removed an interim final rule regarding exemptions for individuals authorized to administer the medical imaging drug DaTscan, effective September 11, 2015, following the removal of ioflupane from controlled substance schedules. The rule was published on November 25, 2014.